News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
676,161 Results
Type
Article (47467)
Company Profile (109)
Press Release (628573)
Multimedia
Podcasts (164)
Webinars (26)
Section
Business (198357)
Career Advice (1722)
Deals (31854)
Drug Delivery (205)
Drug Development (80212)
Employer Resources (95)
FDA (17313)
Job Trends (13713)
News (310130)
Policy (33901)
Tag
2025 Best Places to Work (13)
2026 Best Places to Work (16)
2027 BioCapital Standard (3)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (4)
2027 Biotech Beach Standard (2)
2027 Genetown Elite (1)
2027 Genetown Standard (2)
2027 Pharm Country Standard (4)
40 Under 40 (3)
Academia (2681)
Academic (1)
Accelerated approval (74)
ADA (54)
Adcomms (41)
Allergies (220)
Alliances (44740)
ALS (275)
Alzheimer's disease (2092)
Antibody-drug conjugate (ADC) (785)
Approvals (17943)
Artificial intelligence (1001)
ASCO (331)
Autoimmune disease (508)
Automation (69)
Bankruptcy (303)
Belgium (45)
Best Places to Work (11206)
BIO (74)
Biologics (113)
BIOSECURE Act (17)
Biosimilars (275)
BioSpace Insights (135)
Biotechnology (82)
Bispecific (61)
Bladder cancer (235)
Brain cancer (102)
Breast cancer (970)
Cancer (7735)
Cardiovascular disease (635)
Career advice (1454)
Career pathing (42)
CAR-T (402)
CDC (50)
CDMO (190)
Celiac Disease (6)
Cell therapy (1076)
Cervical cancer (62)
Clinical research (72077)
Collaboration (2687)
Commercialization (69)
Company closure (8)
Compensation (1717)
Complete response letters (127)
COVID-19 (2649)
CRISPR (115)
CRO (8)
C-suite (1548)
Cystic fibrosis (176)
Data (10954)
Decentralized trials (4)
Denatured (34)
Depression (220)
Dermatology (206)
Diabetes (811)
Diagnostics (7123)
Digital health (71)
Diversity (12)
Diversity, equity & inclusion (25)
Drug discovery (511)
Drug pricing (250)
Drug shortages (41)
Duchenne muscular dystrophy (365)
Earnings (75768)
Editorial (74)
Employer branding (15)
Employer resources (94)
ESMO (430)
Events (110513)
Executive appointments (1242)
Eye disease (27)
FDA (22367)
Fibrodysplasia Ossificans Progressiva (17)
Fragile X (5)
Friedreich's ataxia (28)
Frontotemporal dementia (42)
Funding (2102)
Gene editing (259)
Generative AI (87)
Gene therapy (854)
GLP-1 (1342)
Government (4978)
Grass and pollen (7)
Guidances (438)
Healthcare (19112)
Hematology (220)
HIV (121)
Huntington's disease (82)
Idiopathic pulmonary fibrosis (14)
IgA nephropathy (152)
Immunology and inflammation (386)
Immuno-oncology (160)
Indications (294)
Infectious disease (3052)
Inflammatory bowel disease (269)
Inflation Reduction Act (17)
Influenza (147)
Intellectual property (376)
Interviews (320)
IPO (15407)
IRA (61)
Job creations (2776)
Job search strategy (1194)
JPM (59)
Kidney cancer (31)
Kidney disease (174)
Labor market (82)
Layoffs (557)
Leadership (43)
Legal (7289)
Licensing (133)
Liver cancer (114)
Longevity (48)
Lung cancer (1072)
Lung diease (28)
Lymphoma (555)
Machine learning (75)
Management (37)
Manufacturing (1444)
Marketing (41)
MASH (259)
Medical affairs (6)
Medical device (13416)
Medtech (13714)
Melanoma (188)
Mergers & acquisitions (17924)
Metabolic disorders (2075)
Middle East (2)
mRNA (261)
Multiple sclerosis (253)
Multispecific (5)
NASH (23)
Netherlands (40)
Neurodegenerative disease (602)
Neuropsychiatric disorders (150)
Neuroscience (4197)
Neurotech (2)
NextGen: Class of 2026 (6273)
Non-profit (4443)
Now hiring (81)
Obesity (976)
Opinion (355)
Ovarian cancer (295)
Pain (341)
Pancreatic cancer (452)
Parkinson's disease (473)
Partnered (43)
Patents (764)
Patient advocacy (8)
Patient recruitment (944)
Patient selection (123)
Peanut (73)
People (53520)
Peptides (45)
Pharmaceutical (26)
Pharmacy benefit managers (42)
Phase 1 (22073)
Phase 2 (31548)
Phase 3 (24093)
Pipeline (14341)
Policy (376)
Postmarket research (2867)
Preclinical (9374)
Press Release (66)
Prostate cancer (390)
Psychedelics (98)
Radioligand (2)
Radiopharmaceuticals (406)
Rare diseases (1517)
Real estate (4708)
Recruiting (41)
Regenerative medicine (35)
Regulatory (29052)
Reports (50)
Research institute (2470)
Resumes & cover letters (304)
Rett syndrome (57)
RNA editing (29)
RSV (84)
Saudi Arabia (1)
Schizophrenia (225)
Series A (364)
Series B (247)
Series C (1)
Service/supplier (6)
Sickle cell disease (138)
Special edition (25)
Spinal muscular atrophy (192)
Sponsored (46)
Startups (3182)
State (2)
Stem cells (6)
Stomach cancer (22)
Substance use disorders (22)
Supply chain (151)
Switzerland (24)
Tariffs (95)
Tax incentives (1)
The Weekly (127)
Vaccines (1119)
Venture capital (137)
Weight loss (647)
Wet AMD (7)
Women's health (161)
Worklife (16)
Date
Last 7 days (662)
Last 30 days (3427)
Last 365 days (30979)
2026 (28599)
2025 (30134)
2024 (34816)
2023 (39712)
2022 (49953)
2021 (54087)
2020 (52693)
2019 (45688)
2018 (34616)
2017 (31586)
2016 (29810)
2015 (34466)
2014 (25547)
2013 (20944)
2012 (22547)
2011 (23899)
2010 (21524)
Location
Africa (737)
Alabama (111)
Alaska (5)
Arizona (356)
Arkansas (14)
Asia (40439)
Australia (6758)
California (16179)
Canada (4564)
China (1956)
Colorado (728)
Connecticut (739)
Delaware (504)
Europe (92756)
Florida (2507)
Georgia (527)
Hawaii (4)
Idaho (50)
Illinois (1342)
India (141)
Indiana (696)
Iowa (33)
Japan (756)
Kansas (144)
Kentucky (52)
Louisiana (66)
Maine (99)
Maryland (1921)
Massachusetts (11645)
Michigan (404)
Minnesota (837)
Mississippi (6)
Missouri (179)
Montana (34)
Nebraska (26)
Nevada (194)
New Hampshire (90)
New Jersey (4403)
New Mexico (29)
New York (4291)
North Carolina (2093)
North Dakota (11)
Northern California (8377)
Ohio (490)
Oklahoma (24)
Oregon (44)
Pennsylvania (3163)
Puerto Rico (37)
Rhode Island (57)
South America (1005)
South Carolina (65)
South Dakota (1)
Southern California (6533)
Tennessee (276)
Texas (2670)
United States (57234)
Utah (484)
Vermont (1)
Virginia (398)
Washington D.C. (74)
Washington State (1241)
West Virginia (2)
Wisconsin (166)
Wyoming (5)
676,161 Results for "drug information association".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Cardiovascular disease
Novo’s troubled cardio drug could find niche in less sick patients
At the American Heart Association conference, investigators were supportive of further studying Novo’s IL-6 inhibitor ziltivekimab in patients with less severe cardiovascular and kidney disease.
November 9, 2026
·
1 min read
·
Annalee Armstrong
Press Releases
Phillips Medisize to Present Evidence-Based Framework for High-Dose Subcutaneous Drug Delivery at the 2026 Parenteral Drug Association (PDA) Universe of Pre-Filled Syringes and Injection Devices Conference
October 6, 2026
·
3 min read
Press Releases
GENFIT Reports Third Quarter 2026 Financial Information and Provides Corporate Update
November 6, 2026
·
13 min read
Rare diseases
Neurocrine defends Prader-Willi drug after another patient death
Neurocrine Biosciences will conduct a new study for the rare disease drug Vykat to explore dosing and safety in patients with Prader-Willi syndrome who have complex health issues.
November 3, 2026
·
3 min read
·
Annalee Armstrong
Press Releases
Cytokinetics Announces Prescribing Information for MYQORZO® (aficamten) Expanded to Include Data from Phase 3 MAPLE-HCM
November 16, 2026
·
12 min read
Insights
The untapped potential of drug repurposing
In this episode of Denatured, you’ll hear from Daniel Tillett, CEO of Racura Oncology and Sten Sörensen, CEO of Cereno Scientific. We explore why the FDA is now prioritizing drug repurposing, and what it will take to turn existing molecules into viable new therapies.
November 19, 2026
·
1 min read
·
Jennifer C. Smith-Parker
Press Releases
IPS HEART Secures 8th FDA Regulatory Milestone with Rare Pediatric Drug Designation for Cardiomyopathy Associated with Muscular Dystrophies
August 6, 2026
·
2 min read
Opinion
Convert nonresponder insights into smarter drug development strategies in immunology
While agents like AbbVie’s Humira have transformed the treatment landscape, not all patients benefit equally from the drug. Better biomarker analysis and more investment in mechanistic trials can inform the development of more effective therapies with broader clinical value.
June 18, 2026
·
5 min read
·
Kori Wallace
Press Releases
Arboretum Launches to Redefine Precision Medicine for Common Diseases as a Next-Generation Molecular Information Company
October 6, 2026
·
6 min read
Press Releases
Tiziana to Host Investor Call with Key Opinion Leaders to Discuss Positive Phase 2a INFORM-MS Topline Results
November 6, 2026
·
8 min read
1 of 67,617
Next